bioAffinity Technologies Inc.

10/07/2024 | Press release | Distributed by Public on 10/07/2024 06:00

Proxy Results Form 8 K

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the 2024 Special Meeting of Stockholders (the "2024 Special Meeting") of bioAffinity Technologies, Inc. (the "Company") held on October 2, 2024, the Company's stockholders voted on two proposals, each of which is listed below and described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on September 5, 2024 (the "Proxy Statement"). With respect to each proposal, holders of the Company's common stock, par value $0.007 per share (the "Common Stock"), were entitled to cast one vote per share of Common Stock held as of the close of business on the record date of August 30, 2024 (the "Record Date"). On the Record Date there were 13,490,273 shares of the Company's Common Stock issued and outstanding and entitled to vote at the 2024 Special Meeting.

The following are the final results of voting on each of the proposals presented at the 2024 Special Meeting:

Proposal No. 1: Issuance of Shares of Common Stock Upon Exercise of Warrants

The Company's stockholders approved the issuance of up to an aggregate of 1,801,944 shares of Common Stock upon the exercise of Common Stock purchase warrants issued to institutional investors and designees of the placement agent in connection with the Company's registered direct offering and concurrent private placement offering and the Company's warrant inducement transaction.

Votes For Votes Against Abstentions Broker Non-Votes
7,181,952 224,865 146,838 0

Proposal No. 2: Adjournment of the 2024 Special Meeting

The Company's stockholders approved the adjournment of the 2024 Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 1. However, such an adjournment was not necessary in light of the approval of Proposal No. 1 at the 2024 Special Meeting.

Votes For Votes Against Abstentions Broker Non-Votes
7,093,892 225,886 233,277 0